Tampa, Fla.-based Moffitt Cancer Center recorded an operating income of $63.7 million (7.3% operating margin) during the third quarter of fiscal 2026, up from $40.2 million (5.2% margin) during the same period last year, according to its May 6 financial report.
For the three months ended March 31, Moffitt reported total operating revenue of $868.4 million, a 12.8% increase year over year. Patient service revenue increased 12.4% to $746.8 million.
Total operating expenses were $804.7 million in the third quarter of 2026, a 10.2% increase year over year. Salaries, wages and benefits increased 10.3% to $357.9 million. Supply expenses increased 11.6% year over year to $312.2 million. Purchased services increased 10.5% to $64.4 million.
Moffitt reported a net income of $60.9 million in the third quarter of 2026, up from $52.4 million during the same period last year.
For the nine months ended March 31, Moffitt reported an operating income of $174.8 million (6.9% operating margin), up from $73.7 million (3.4% margin) during the same period last year.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
